A 55-year-old African American male with a history of untreated HIV presented with bilateral lower extremity weakness, ataxia, and diplopia for 3 weeks. His initial examination showed muscle weakness in the upper and lower limbs, diplopia, ataxia, and areflexia. CSF analysis showed albuminocytologic dissociation and a negative meningitis panel. Electrodiagnostic studies showed a sensorimotor mixed polyneuropathy. Serum GQ1B antibody, CSF oligoclonal bands and IGG index were positive. He was diagnosed with MFS, received a course of IVIG with clinical improvement. He was discharged on HAART therapy.
He presented 2 months later with worsening symptoms. His CD4 count increased from 50 to 200. Brain MRI showed a faintly enhancing T2 hyperintense lesion involving the cerebellum and brainstem. Repeat LP showed elevated protein and WBC, as well as EBV positivity on PCR and monoclonal B cells on flow cytometry. He was then started on steroids, with marginal improvement. Repeat imaging showed rapid expansion of the previously shown lesion. MR spectroscopy favored an infectious/demyelinating process. Brain stereotactic biopsy was positive for JCV and demonstrated PML as well as B-Cell Clonality. Oncology deemed the B-Cell Clonality nonconfirmative in the setting of PML.